Growth Arrest Specific-6 and Axl Coordinate Inflammation and Hypertension. Issue 11 (12th November 2021)
- Record Type:
- Journal Article
- Title:
- Growth Arrest Specific-6 and Axl Coordinate Inflammation and Hypertension. Issue 11 (12th November 2021)
- Main Title:
- Growth Arrest Specific-6 and Axl Coordinate Inflammation and Hypertension
- Authors:
- Van Beusecum, Justin P.
Barbaro, Natalia R.
Smart, Charles D.
Patrick, David M.
Loperena, Roxana
Zhao, Shilin
de la Visitacion, Nestor
Ao, Mingfang
Xiao, Liang
Shibao, Cyndya A.
Harrison, David G. - Abstract:
- Abstract : Rationale: There is an intimate relationship between the endothelium and monocytes, and activated endothelial cells promote monocyte transformation to macrophages and dendritic cells (DCs). Recently, a subset of human DCs expressing the receptor tyrosine kinase, Axl and the lectin siglec-6 has been described and termed (AS) DCs. Objective: We sought to determine if circulating AS DCs are increased in human hypertension and to examine how Axl signaling contributes to this disease. Methods and Results: We demonstrated that circulating AS DCs are increased in hypertensive humans compared with normotensive controls. Pulse pressure in humans also correlated with plasma levels of the Axl agonist GAS6 (growth arrest specific 6). Exposure of human endothelial cells to 10% cyclical stretch increased release of the GAS6, promoted Axl signaling and caused AS DC formation; events that were inhibited by blockade of Axl with R428 or by siRNA knockdown of either endothelial GAS6 or Axl. GAS6/Axl signaling in human monocytes potentiated interleukin 1β production through NLRP3 (nucleotide-binding oligomerization domain, leucine rich tepeat and pyrin domain containing protein)/caspase-1 and caused accumulation of immunogenic isoLG (isolevuglandin)-protein adducts. In mice, the Axl inhibitor R428 or global deletion of Axl attenuated hypertension and renal inflammation caused by Ang II (angiotensin II) infusion. Bone marrow transplant studies demonstrated a role of both stromal andAbstract : Rationale: There is an intimate relationship between the endothelium and monocytes, and activated endothelial cells promote monocyte transformation to macrophages and dendritic cells (DCs). Recently, a subset of human DCs expressing the receptor tyrosine kinase, Axl and the lectin siglec-6 has been described and termed (AS) DCs. Objective: We sought to determine if circulating AS DCs are increased in human hypertension and to examine how Axl signaling contributes to this disease. Methods and Results: We demonstrated that circulating AS DCs are increased in hypertensive humans compared with normotensive controls. Pulse pressure in humans also correlated with plasma levels of the Axl agonist GAS6 (growth arrest specific 6). Exposure of human endothelial cells to 10% cyclical stretch increased release of the GAS6, promoted Axl signaling and caused AS DC formation; events that were inhibited by blockade of Axl with R428 or by siRNA knockdown of either endothelial GAS6 or Axl. GAS6/Axl signaling in human monocytes potentiated interleukin 1β production through NLRP3 (nucleotide-binding oligomerization domain, leucine rich tepeat and pyrin domain containing protein)/caspase-1 and caused accumulation of immunogenic isoLG (isolevuglandin)-protein adducts. In mice, the Axl inhibitor R428 or global deletion of Axl attenuated hypertension and renal inflammation caused by Ang II (angiotensin II) infusion. Bone marrow transplant studies demonstrated a role of both stromal and immunologic Axl in Ang II–induced hypertension. Lastly, in freshly harvested human endothelial cells, a striking correlation was observed between the degree of endothelial cell activation as reflected by ICAM-1 (intracellular adhesion molecule 1), isoLG-adduct accumulation, and intracellular GAS6 levels. Conclusions: We define a previously unrecognized interaction of human endothelial cells and monocytes that promote formation of AS DCs in hypertension and show a critical role of GAS6 and Axl signaling in both immune cells and endothelial cells. This pathway is potentially a novel therapeutic target to reduce inflammation and end organ damage in hypertension. Abstract : Supplemental Digital Content is available in the text. … (more)
- Is Part Of:
- Circulation research. Volume 129:Issue 11(2021)
- Journal:
- Circulation research
- Issue:
- Volume 129:Issue 11(2021)
- Issue Display:
- Volume 129, Issue 11 (2021)
- Year:
- 2021
- Volume:
- 129
- Issue:
- 11
- Issue Sort Value:
- 2021-0129-0011-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-11-12
- Subjects:
- blood pressure -- hypertension -- inflammation -- macrophages -- plasma
Cardiovascular system -- Periodicals
Blood -- Circulation -- Periodicals
Blood Circulation
Cardiovascular System
Vascular Diseases
Sang -- Circulation -- Périodiques
Appareil cardiovasculaire -- Périodiques
612.1 - Journal URLs:
- http://circres.ahajournals.org/ ↗
http://www.circresaha.org ↗
http://journals.lww.com ↗ - DOI:
- 10.1161/CIRCRESAHA.121.319643 ↗
- Languages:
- English
- ISSNs:
- 0009-7330
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3265.300000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 25060.xml